Nasdaq
RNTX
Rein Therapeutics, Inc.
- Health Care
- Listed 2017
- 1 day
- +10.4%
- 1 month
- −21.9%
- 1 year
- −31.7%
$0.7885 · Mkt cap $67.4M
At the 6 Aug 2026 close
Nasdaq
Rein Therapeutics, Inc.
$0.7885 · Mkt cap $67.4M
At the 6 Aug 2026 close
Rein Therapeutics, Inc. trades under the ticker RNTX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2017. Its market capitalisation is $67.4M. The last closing price was $0.7885, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −31.7%, and −21.9% over the past month. Returns are price returns and exclude dividends.
This page exists because RNTX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.